Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
A Democratic challenger who said she intends to drop out of November’s race for the US...
Ukraine said its forces struck a Russian warship capable of launching Kalibr cruise missiles during overnight...
Nobel Peace laureate and activist Narges Mohammadi has been transferred to a Tehran hospital more than...
New York City mayor Zohran Mamdani on Wednesday slammed an Israeli real estate expo at a...
